PedAM
Pediatric Disease Annotations & Medicines
| Disease | lipodystrophy |
| Phenotype | C0028754|adiposity |
| Sentences | 2 |
| PubMedID- 22050344 | Although long-term clinical experience is needed to further assess the benefits and risks of therapy, current evidence suggests that tesamorelin may be useful for reducing visceral adiposity in patients with hiv-associated lipodystrophy, thereby potentially improving self image. |
| PubMedID- 21668043 | Although long-term clinical experience is needed to further assess the benefits and risks of therapy, current evidence suggests that tesamorelin may be useful for reducing visceral adiposity in patients with hiv-associated lipodystrophy, thereby potentially improving self image. |
Page: 1